NATURE’S SUNSHINE PRODUCTS, INC. Proceeds from Notes Payable
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-03-08
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from notes payable for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from notes payable for the quarter ending 2021-09-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from notes payable for the quarter ending 2020-12-31 was $3.72M.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from notes payable for the quarter ending 2020-09-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from notes payable for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from notes payable for fiscal 2020 was $9.10M.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from notes payable for fiscal 2019 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-03-08 | $0.00 10-K · filed 2022-03-08 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | $3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $3.72M derived: sum of 2 quarters · filed 2022-03-08 | $9.10M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $5.37M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $5.37M 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $0.00 derived: sum of 2 quarters · filed 2021-03-10 | $0.00 10-K · filed 2021-03-10 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |